IL160722A0 - Aryloxypropylamines as chemosensitizing agents in the treatment of cancer - Google Patents
Aryloxypropylamines as chemosensitizing agents in the treatment of cancerInfo
- Publication number
- IL160722A0 IL160722A0 IL16072202A IL16072202A IL160722A0 IL 160722 A0 IL160722 A0 IL 160722A0 IL 16072202 A IL16072202 A IL 16072202A IL 16072202 A IL16072202 A IL 16072202A IL 160722 A0 IL160722 A0 IL 160722A0
- Authority
- IL
- Israel
- Prior art keywords
- aryloxypropylamines
- cancer
- treatment
- chemosensitizing agents
- chemosensitizing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/948,621 US6630454B2 (en) | 2001-09-10 | 2001-09-10 | Method and pharmaceutical composition for the treatment of cancer |
PCT/IL2002/000750 WO2003022258A1 (fr) | 2001-09-10 | 2002-09-10 | Aryloxypropylamines utilisees en tant qu'agent chimiosensibilisateur dans le traitement du cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
IL160722A0 true IL160722A0 (en) | 2004-08-31 |
Family
ID=25488062
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL16072202A IL160722A0 (en) | 2001-09-10 | 2002-09-10 | Aryloxypropylamines as chemosensitizing agents in the treatment of cancer |
Country Status (7)
Country | Link |
---|---|
US (3) | US6630454B2 (fr) |
EP (1) | EP1425002A1 (fr) |
JP (1) | JP2005505559A (fr) |
KR (1) | KR20050026903A (fr) |
CA (1) | CA2460022A1 (fr) |
IL (1) | IL160722A0 (fr) |
WO (1) | WO2003022258A1 (fr) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994006422A1 (fr) * | 1992-09-22 | 1994-03-31 | The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services | Utilisation de taxol pour traiter des lymphomes et des cancers du sein |
US8050964B2 (en) * | 1999-05-06 | 2011-11-01 | Etagz, Inc. | Computer-readable medium product label apparatus and method |
US6630454B2 (en) * | 2001-09-10 | 2003-10-07 | Ramot At Tel-Aviv University Ltd. | Method and pharmaceutical composition for the treatment of cancer |
CN1281210C (zh) * | 2003-11-29 | 2006-10-25 | 胡汛 | 五味子乙素在制备治疗肿瘤药物中的应用 |
US20060024722A1 (en) * | 2004-07-30 | 2006-02-02 | Mark Fischer-Colbrie | Samples for detection of oncofetal fibronectin and uses thereof |
WO2006078774A2 (fr) * | 2005-01-19 | 2006-07-27 | The Trustees Of The University Of Pennsylvania | Regulation de l'autophagie et de la survie cellulaire |
WO2008081477A1 (fr) * | 2007-01-04 | 2008-07-10 | Natco Pharma Limited | Propanamines à 3-substitution 3-aryloxy |
WO2021236498A1 (fr) * | 2020-05-18 | 2021-11-25 | Yale University | Traitement de cancers à variant kras avec des inhibiteurs d'absorption de la sérotonine |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4314081A (en) | 1974-01-10 | 1982-02-02 | Eli Lilly And Company | Arloxyphenylpropylamines |
US4018895A (en) | 1974-01-10 | 1977-04-19 | Eli Lilly And Company | Aryloxyphenylpropylamines in treating depression |
US4318477A (en) * | 1980-09-22 | 1982-03-09 | Kerpe Stase Z | Pharmaceutical package |
DE3587465T2 (de) * | 1984-09-10 | 1994-01-20 | Hsc Res Dev Corp | Vielfache Drogen-Resistenz in Säugetierzellinien und Isolierung der determinanten Glykoprotein-DNS. |
US5194428A (en) | 1986-05-23 | 1993-03-16 | Worcester Foundation For Experimental Biology | Inhibition of influenza virus replication by oligonucleotide phosphorothioates |
GB8626936D0 (en) * | 1986-11-11 | 1986-12-10 | Ferrosan As | Treatment |
US5110802A (en) | 1987-07-14 | 1992-05-05 | City Of Hope | Oligonucleotide phosphonates and method of inhibiting a human immunodeficiency virus in vitro utilizing said oligonucleotide phosphonates |
US5216141A (en) | 1988-06-06 | 1993-06-01 | Benner Steven A | Oligonucleotide analogs containing sulfur linkages |
US5166437A (en) | 1989-03-03 | 1992-11-24 | Orion-Yhtyma Oy | Process for the preparation of fluoxetine |
JP2706371B2 (ja) * | 1990-12-17 | 1998-01-28 | ユニヴァーシティー オブ マニトバ | 癌治療用補助剤及びそれを用いたキット |
US5798339A (en) | 1990-12-17 | 1998-08-25 | University Of Manitoba | Treatment method for cancer |
GB9303210D0 (en) * | 1993-02-17 | 1993-03-31 | Univ Manitoba | Cancer treatment |
US5639950A (en) * | 1992-09-29 | 1997-06-17 | The Ohio State University Research Foundation | Nucleotide sequence encoding for bifunctional enzyme for proline production |
IL115582A0 (en) * | 1994-10-14 | 1996-01-19 | Lilly Co Eli | Methods for treating resistant tumors |
US5776925A (en) | 1996-01-25 | 1998-07-07 | Pharmacyclics, Inc. | Methods for cancer chemosensitization |
US5795895A (en) * | 1997-06-13 | 1998-08-18 | Anchors; J. Michael | Combination anorexiant drug therapy for obesity using phentermine and an SSRI drug |
EP1048659A4 (fr) | 1997-11-12 | 2002-11-20 | Inst Med Molecular Design Inc | Agonistes du recepteur du retinoide |
US20010041706A1 (en) * | 2000-03-24 | 2001-11-15 | Synold Timothy W. | Blockade of taxane metabolism |
US6927223B1 (en) * | 2000-05-26 | 2005-08-09 | Washington State University Research Foundation | Use of serotonin agents for adjunct therapy in the treatment of cancer |
IL139975A0 (en) * | 2000-11-29 | 2002-02-10 | Univ Ramot | Anti proliferative drugs |
US6258853B1 (en) | 2001-01-31 | 2001-07-10 | Grayson Walker Stowell | Form a of fluoxetine hydrochloride |
US6630454B2 (en) * | 2001-09-10 | 2003-10-07 | Ramot At Tel-Aviv University Ltd. | Method and pharmaceutical composition for the treatment of cancer |
-
2001
- 2001-09-10 US US09/948,621 patent/US6630454B2/en not_active Expired - Fee Related
-
2002
- 2002-09-10 US US10/488,095 patent/US20040266882A1/en not_active Abandoned
- 2002-09-10 IL IL16072202A patent/IL160722A0/xx unknown
- 2002-09-10 WO PCT/IL2002/000750 patent/WO2003022258A1/fr not_active Application Discontinuation
- 2002-09-10 CA CA002460022A patent/CA2460022A1/fr not_active Abandoned
- 2002-09-10 JP JP2003526387A patent/JP2005505559A/ja active Pending
- 2002-09-10 EP EP02777752A patent/EP1425002A1/fr not_active Withdrawn
- 2002-09-10 KR KR1020047003530A patent/KR20050026903A/ko not_active Application Discontinuation
-
2003
- 2003-03-10 US US10/383,748 patent/US20040054014A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2460022A1 (fr) | 2003-03-20 |
KR20050026903A (ko) | 2005-03-16 |
WO2003022258A1 (fr) | 2003-03-20 |
US20040266882A1 (en) | 2004-12-30 |
US20030087964A1 (en) | 2003-05-08 |
JP2005505559A (ja) | 2005-02-24 |
EP1425002A1 (fr) | 2004-06-09 |
US20040054014A1 (en) | 2004-03-18 |
US6630454B2 (en) | 2003-10-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL251270A0 (en) | Cancer treatment | |
PL370029A1 (en) | 2-amino-4-heteroarylaminopyrimidine derivatives for use in the treatment of cancer | |
AU6147401A (en) | Compositions and methods for the treatment of cancer | |
AU2003213144A1 (en) | Alkylating agent combinations in the treatment of cancer | |
HK1086488A1 (en) | Compound and use thereof for the treatment of cancer | |
AU6048201A (en) | Quinazoline derivatives for the treatment of tumours | |
GB0112343D0 (en) | Well treatment | |
HK1072443A1 (en) | Immunoconjugates for the treatment of tumours | |
HK1061212A1 (en) | Pyranoindazoles and their use for the treatment ofglaucoma | |
AU2003212634A8 (en) | Compounds useful in the treatment of cancer | |
PL368458A1 (en) | Improved use of antitumoral compound in cancer therapy | |
HUP0500424A3 (en) | Combination therapy for the treatment of cancer | |
HUP0400609A3 (en) | Wet-skin treatment compositions | |
MXPA03008582A (es) | Agentes y metodos para tratamiento de cancer. | |
HUP0300339A3 (en) | Use of fulvestrant in the treatment of resistant breast cancer | |
PL368035A1 (en) | Compositions and methods for the treatment of cancer | |
IL160722A0 (en) | Aryloxypropylamines as chemosensitizing agents in the treatment of cancer | |
GB0026015D0 (en) | Cancer treatment | |
EP1684795A4 (fr) | Procedes et agents pour le traitement du cancer | |
GB0119370D0 (en) | Therapeutic agent | |
EP1463511A4 (fr) | Therapie anticancereuse combinatoire | |
AU2003247094A8 (en) | Enhancing the effect of radioimmunotherapy in the treatment of tumors | |
GB0105244D0 (en) | Cancer treatment methods and compositions | |
AU2002357468A1 (en) | Use of 2-acylindoles in the treatment of tumors | |
GB0130694D0 (en) | Treatment |